Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Universite de Bordeaux |
| Country | France |
| Start Date | Jan 01, 2023 |
| End Date | Dec 31, 2026 |
| Duration | 1,460 days |
| Number of Grantees | 14 |
| Roles | Participant; Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101086247 |
The PSYchiatric disorders and COmorbidities caused by pollution in the MEDiterranean area (PsyCoMed) project proposes a MSCA-Staff Exchange program that aims to characterise the role of anthropogenic pollutants in the Mediterranean area as a risk factor of neuropsychiatric disorders and associated pathologies, and the role of neuroinflammatory responses in the disease progression.
The consortium comprises 11 beneficiaries (8 academic, 3 SMEs) and 3 TC partners putting together complementary expertises in environmental and life sciences (academics) and analytical biology or natural therapeutic phytocompounds (SMEs).
Through a multi-scale (from molecular to clinical science), multi-modal (from mechanistic to behavioural approaches), and inter-sectoral strategy, PsyCoMed will correlate the effects of pollutants on psychiatric symptoms with alterations of inflammatory pathways in animal models and psychiatric patients.
We will investigate neural mechanisms underlying pathological changes in vitro and in in vivo preclinical models.
Natural substances with therapeutic potential will be tested for their ability to restore healthy mechanisms and alleviate pathological symptoms in animal models.
PsyCoMed offers a unique framework to build a network synergy by bringing together themes and scientific practises in the Mediterranean area.
The partners will share knowledge/know-how through secondments and workshops in support of PsyCoMed scientific objectives. This will improve the skills of staff members and their opening to the academic and private sectors.
By proposing common protocols and experimental design, the participants will foster standardization of experimental procedures and diffusion of good laboratory practise.
At a global level, the consortium will acquire the capacity to tackle complex neurobiological challenges, while building long-lasting collaborations. PsyCoMed will provide decision-makers with the ground for public health orientations with societal impact.
Universitat Jaume I de Castellon; Universite Cadi Ayyad; Flanat Research Italia Srl; Benephyt; Universite de Tunis El Manar; Alexandria University; Consiglio Nazionale Delle Ricerche; Universite de Bordeaux; The Florey Institute of Neuroscience and Mental Health; Universita Ta Malta; Universite de Saint Esprit-Kaslik Autorite Religieuse; Watchfrog; Centre National de la Recherche Scientifique CNRS; Uniwersytet Jagiellonski
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant